• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

FDA clears Longport scanner

Article

Ultrasound device developer Longport received good news last month when the Food and Drug Administration cleared its Longport Digital Scanner (LDS), a portable ultrasound scanner that captures and reproduces images of soft tissue down to 2 cm. Longport

Ultrasound device developer Longport received good news last month when the Food and Drug Administration cleared its Longport Digital Scanner (LDS), a portable ultrasound scanner that captures and reproduces images of soft tissue down to 2 cm. Longport applied for 510(k) clearance for the unit in January (SCAN 1/13/99).

The clearance covers dermatological indications, but the Swarthmore, PA, firm is researching other uses for the device, such as podiatric, physical therapy, dental, and burn treatment indications. The company plans to rent the unit to clients in a range of settings, including private physician offices and outpatient centers. Rental will cost about $4000 per month, and will include service, upgrades, and access to an Internet educational database. Longport has a waiting list for LDS of more than 100 clients, the company said.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.